Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Net Issuance of Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Net Issuance of Debt Peer Comparison

Comparables:
688235
6550

Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Debt CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Net Issuance of Debt
-NT$153.7m
CAGR 3-Years
-24%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Net Issuance of Debt
ÂĄ2.5B
CAGR 3-Years
9%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Net Issuance of Debt
NT$860.9m
CAGR 3-Years
778%
CAGR 5-Years
89%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Net Issuance of Debt?
Net Issuance of Debt
-153.7m TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Net Issuance of Debt amounts to -153.7m TWD.

What is Tanvex BioPharma Inc's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 5Y
-36%

Over the last year, the Net Issuance of Debt growth was -26%. The average annual Net Issuance of Debt growth rates for Tanvex BioPharma Inc have been -24% over the past three years , -36% over the past five years .

Back to Top